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Summary
Periventricular heterotopia (PVH) is a congenital
malformation of human cerebral cortex frequently
associated with Filamin-A (FLN-A) mutations but the
pathogenetic mechanisms remain unclear. Here, we
show that the MEKK4 (MAP3K4) pathway is involved
in Fln-A regulation and PVH formation. MEKK42/2
mice developed PVH associated with breaches in the
neuroependymal lining which were largely comprised
of neurons that failed to reach the cortical plate. RNA
interference (RNAi) targeting MEKK4 also impaired
neuronal migration. Expression of Fln was elevated
inMEKK42/2 forebrain,most notably near sites of failed
neuronal migration. Importantly, recombinant MKK4
protein precipitated a complex containing MEKK4 and
Fln-A, and MKK4 mediated signaling between MEKK4
and Fln-A, suggesting that MKK4 may bridge these
molecules during development. Finally, we showed
that wild-type FLN-A overexpression inhibited neuro-
nal migration. Collectively, our results demonstrate
a link betweenMEKK4 andFln-A that impacts neuronal
migration initiation and provides insight into the path-
ogenesis of human PVH.
Introduction
Cerebral cortical development is a dynamic process that
requires complex but precise coordination of cell prolif-
eration, death, migration, and differentiation (Marin and
Rubenstein, 2003; Rakic, 1988b). Cortical malformations
are often associated with mutations in genes that regu-
late each of these processes (Bielas et al., 2004; Haydar
et al., 1999; Rakic, 1988a; Walsh, 1999). Mitogen-acti-
vated protein kinases (MAPKs) are intracellular signal
transduction molecules expressed in all eukaryotic cells
that modulate these basic cellular events by responding
to context-dependent extracellular signals (Morrison
and Davis, 2003). MAPKs are activated via signaling
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5 These authors contributed equally to this work.cascades involving MAPK kinases (MAP2Ks) that are in
turn activated by MAPK kinase kinases (MAP3Ks). There
are five major subgroups of MAPKs, namely ERK1/2,
JNK, p38, ERK5, and ERK7 (Johnson et al., 2005). The
c-Jun NH2-terminal kinase (JNK) subgroup of MAPKs
has been reported to affect region-specific cell death
during early CNS development (Kuan et al., 2000). More
recently, JNK was shown to regulate cytoskeletal move-
ment and cell migration by maintaining microtubule
stability (Chang et al., 2003; Huang et al., 2003). JNK
binds and phosphorylates the microtubule associated
protein, doublecortin (DCX) in growth cones of migrating
neurons (Gdalyahu et al., 2004), and overexpression of
either dominant-negative JNK or MUK (a mixed lineage
kinase and regulator of JNK activity) can impede radial
neuronal migration (Hirai et al., 2002; Hirai et al., 2005;
Kawauchi et al., 2003). One of the MAP2Ks that activates
JNK, MKK4 (also known as SEK1), can interact with Fila-
min-A (FLN-A), an actin-binding protein essential for
cytoskeletal rearrangement and cell locomotion (Marti
et al., 1997; Stossel et al., 2001). DCX and FLN-A muta-
tions in human cause subcortical band and periventricu-
lar nodular heterotopias, respectively (Fox et al., 1998;
Gleeson et al., 1998). Thus, JNK or its upstream regula-
tors may be involved in the pathogenesis of these human
disorders. How this pathway is regulated during neural
development remains poorly understood.
MEKK4 (MTK1 in human) is one of w17 MAP3Ks
cloned from mammalian cells that affects the activity of
downstream MAP2Ks and MAPKs including JNK and
p38 (Gerwins et al., 1997; Takekawa et al., 2005).
MEKK4 activity is stimulated by growth factors (e.g.,
EGF), inflammatory cytokines (e.g., angiotensin II), and
environmental stress (e.g., MMS, UV and g irradiation;
Abell et al., 2005; Derbyshire et al., 2005; Fanger et al.,
1997; Gerwins et al., 1997). Mice deficient in MEKK4 or
possessing kinase-dead MEKK4 (MEKK4K1361R) develop
CNS phenotypes, including severe neural tube closure
defects and massive neuroepithelial apoptosis (Abell
et al., 2005; Chi et al., 2005). These mice exhibited
reduced MKK4/SEK1 or MKK3/6 activity in the develop-
ing neuroepithelium but no detectable changes in JNK
activity. The activity of p38, however, was altered in
MEKK4K1361R fibroblasts and affected downstream tar-
gets that possibly contributed to actin cytoskeletal
breakdown. Thus, MEKK4 activity may be necessary
for the integrity and rearrangement of the actin cytoskel-
eton (Abell et al., 2005; Yuzyuk and Amberg, 2003). Nota-
bly, MEKK42/2 mice frequently develop PVH that mani-
fest as cell accumulations lining and protruding into the
lateral ventricles (Chi et al., 2005). This suggests that
MEKK4 may be required for cytoskeletal stability or in-
tegrity of the ventricular surface lining the developing
forebrain (FB) which could influence neuronal migration
away from the proliferative zone (PZ). Because a role
for MEKK4 in developing FB is unknown, we hypothe-
sized that MEKK4 regulates migration within and/or
away from the cortical PZ by regulating key modulators
of the actin cytoskeleton suspected to be essential
during this process.
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mouse and human FB. PVH in MEKK42/2 mice arise from
breaches in the ventricular surface lining and are largely
comprised of postmitotic neurons. Cells within PVH fail to
leave the VZ surface and migrate into the CP. Likewise; in
utero electroporation of short interference RNA (siRNA)
against MEKK4 impairs neuronal migration. Surprisingly,
MEKK4 suppression results in abnormally high Fln-A ex-
pression and phosphorylation at Ser2152, a residue impli-
cated in Fln-A cleavage and modulation of actin dynamics.
We show that MKK4/SEK1 can interact with and mediate
signaling between MEKK4 and Fln-A. Lastly, overexpres-
sion of FLN-A can inhibit neuronal migration. Together,
our results indicate that MEKK4 contributes to the integrity
of the VZ surface, regulates the amount of Fln, and medi-
ates cell migration during FB development.
Results
MEKK4 Is Expressed in Progenitors and Neurons
in Fetal and Adult Murine and Human Forebrain
MTK1mRNA is ubiquitously expressed in fetal and adult
CNS (Chan-Hui and Weaver, 1998; Takekawa et al.,
1997), although its expression pattern in developing FB
has not been well characterized. In vitro studies have
localized MEKK4 to the cytoplasm and in perinuclear
vesicles (Gerwins et al., 1997; Halfter et al., 2005; Take-
kawa and Saito, 1998). MEKK4 expression during mouse
development was recently reported to be enriched
throughout the entire neural tube as early as embryonic
day (E) 8.5 (Abell et al., 2005; Chi et al., 2005). To better
localize MEKK4 signal in both developing and adult FB,
we probed E16.5 and adult FB sections using in situ
hybridization. MEKK4 expression in the embryo spanned
the telencephalic wall (see Figure S1A in the Supplemen-
tal Data available with this article online) as well as all
neocortical lamina of the adult FB (Figures S1B and
S1C). Next, we performed western blot analysis to deter-
mine whether MEKK4 protein is expressed in developing
human FB. We found that MEKK4 was expressed in
human fetal FB during peak ages of neurogenesis and
migration (Figure S1D). These data indicate that MEKK4
is expressed in neural progenitors and may play multiple
roles throughout development and adulthood.
MEKK42/2 Mice Develop PVH Largely Comprised
of Differentiated Neurons
MEKK4 mutation results in highly penetrant neural tube
defects andw50% of MEKK42/2 mice exhibited cranial
exencephaly (Chi et al., 2005). Among these affected
mice, w70% display highly degenerated FB (‘‘small
FB’’) due to massive apoptosis beginning wE9.5–10.5,
whilew30% display relatively normal size to slightly en-
larged FB (‘‘big FB’’) compared to MEKK4+/+ or +/2 mice
(Chi et al., 2005). Big FB MEKK4 mutants exhibited bilat-
eral PVH that were characterized by focal disruptions of
the VZ/SVZ and cell expansion into the ventricular space
(Figure 1A). The intermediate zone (IZ) was typically thin-
ner than controls. Remarkably, a relatively organized
cortical plate (CP) overlay PVHs, although we periodi-
cally observed subpial ectopias (Figures 1A and 1B)
and polymicrogyria (Figure 1C). It was also not uncom-
mon to observe an overall decrease in CP thickness in
big FB mutants (Figures 1E and 1H). PVH and ectopiaswere present in small FB phenotype as well (see below).
In both phenotypes, disruptions of the VZ surface were
more prevalent than ectopias. These observations sug-
gest that despite a dramatic difference in size and mor-
phology, both small and big FB MEKK4 mutants may
share common molecular mechanisms that contribute
to the disruptions of the ventricular and pial surfaces.
To determine the cellular composition of PVHs, we im-
munostained E18.5 FB with glial (GLAST) and neuronal
(TUJ1) markers. PVHs weakly expressed GLAST
(Figure 1D) but showed strong TUJ1 expression in both
phenotypes (Figures 1E and 1F). Ectopias in small FB
phenotype also expressed TUJ1 (Figure 1G) and Tbr1
(Figure 1G0), a transcription factor expressed by early-
born glutamatergic cortical progenitors soon after differ-
entiation and strongly expressed by layer 6 cells (Hevner
et al., 2001). Tbr1 immunostaining in big FB phenotypes
revealed that PVHs contained many intensely labeled
Tbr1+ cells, suggesting many cells failed to reach layer
6 (Figure 1H). In addition to large PVH, we found Tbr1+
cells within ‘‘normal’’ areas of the VZ (where Tbr1 is nor-
mally absent) in both big (Figure 1I) and small FB (see be-
low) phenotypes. These results suggest that small or
widespread disruptions of the VZ surface in MEKK4 mu-
tants may result in ectopic differentiation and/or in-
hibited migration of cortical neurons.
Failure of BrdU-Positive Cells to Leave the
Ventricular Surface and PVH in MEKK42/2 Embryos
The presence of PVH suggests that some cells are unable
to migrate away from the VZ inMEKK42/2FB. To test this,
we exposed mice to bromodeoxyuridine (BrdU), which is
incorporated into cells during S phase and examined the
fates of BrdU+ cells. Short exposure (1 hr) at E14.5 re-
vealed comparable levels of S phase cells along the VZ
ofMEKK42/2 andMEKK4+/+ mice (data not shown). Lon-
ger exposure (96 hr) at E18.5 in MEKK42/2 mice with big
FB showed heavily labeled BrdU+ cells within PVH
(Figure 2A). BrdU+ cells within PVH were TUJ1+, indicat-
ing that these neurons failed to migrate away from the
PVH (Figure 2A). Consistent with these findings, short ex-
posure (1 hr) of BrdU to E18.5 mice with big FB revealed
that PVH were largely BrdU2 (data not shown), suggest-
ing that PVH are largely differentiated structures. Addi-
tionally, after 96 hr, we observed many heavily labeled
BrdU+ cells at the VZ surface in MEKK42/2 with small
FB phenotype compared to MEKK4+/+ mice (Figure 2B).
These cells were located in abnormally TUJ1+ regions
of the VZ (data not shown). Thus, Tbr1 immunostaining
(Figure 1) combined with the BrdU data suggests that
PVH form during early- to mid-neurogenesis (i.e., E14.5
or earlier) in MEKK42/2 mice with either FB phenotype.
The presence of BrdU+/TUJ1+ cells at the VZ surface
suggests that certain neural progenitors in MEKK42/2
FB have a marked defect in their migratory capacity to
exit the VZ surface. While the most severe defects were
largely restricted to areas of VZ surface disruption, we
cannot rule out more subtle migration defects that may
affect nonheterotopic regions of MEKK42/2 FB.
In Vitro and In Vivo RNAi-Mediated Knockdown
of MEKK4
Deleting the MEKK4 gene on a pure C57BL/6 mouse
background caused neurulation defects wE9.0 that
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791Figure 1. Cortical Malformations in MEKK42/2 Mice
(A) Nissl staining of E17.5MEKK4+/+ andMEKK42/2 (big FB phenotype) coronal forebrain sections. Lower magnification (upper panels) revealed
prominent bilateral PVH (arrows) that disrupted the continuity of the VZ/SVZ. Higher magnification of the telencephalic wall (lower panels) shows
an example of a focal disruption of the VZ surface (arrows). Also observed was reduced thickness of the intermediate zone (IZ) in MEKK42/2
compared to control. The arrowhead points to a small subpial ectopia in the marginal zone (MZ) (arrowhead). Bars (mm) in ([A], upper) = 500,
([A], lower) = 100.
(B) Example of a large subpial ectopia (arrows) overlying a heterotopic area in MEKK42/2 big FB. Bar in (B) = 100 mm.
(C) Example of polymicrogyria (arrows) overlying a heterotopic area in MEKK42/2 big FB.
(D) GLAST immunoreactivity (green) and nuclear staining (blue) of MEKK4+/+ and 2/2 (big FB). Insets of boxed areas of nuclei (blue) show strong
GLAST expression in control VZ (D0) compared to low expression in a PVH (D00, arrow) of the mutant. Bars (mm) in (D) = 100, (D0) = 50.
(E) TUJ1 immunoreactivity showed that PVH protruding into the lateral ventricle (LV) in MEKK42/2 big FB were TUJ1+ (arrows) compared to
MEKK4+/+ (left panel), where the VZ lacked TUJ1. Propidium iodide (PI) was used to label nuclei (red).
(F and G) TUJ1 immunoreactivity (green) and nuclei (red) in MEKK42/2 small FB phenotype.
(F) Example of a PVH (arrow) that disrupted the VZ continuity and strongly expressed TUJ1.
(G) An ectopia disrupting the pial surface that was positive for TUJ1 and Tbr1 (G0). Bars in (G), (G0) = 50 mm.
(H and I) Tbr1 immunoreactivity (red) and TO-PRO-3-labeled nuclei (blue) in MEKK4+/+ and 2/2 big FB.
(H) Low magnification revealed many intensely labeled Tbr1+ cells in layer 6 of +/+ (left panel) and 2/2 (right panel). Note the numerous heavily
labeled Tbr1+ cells (arrows) in 2/2 PVH.
(I) High magnification of the VZ revealed a small cluster of Tbr1+ cells in the mutant VZ (right panels, arrows) compared to +/+ (left panels) where
Tbr1 was normally absent. Bar = 50 mm.spanned the FB and hindbrain neuroepithelium (Chi
et al., 2005). PVH formation and subsequent migration
defects could be secondary to failure of the neural tube
to fuse properly. To circumvent this confounding issue,
we designed siRNA against MEKK4 mRNA to assess
whether depletion of MEKK4 in normal mouse FB neuro-
epitheliumaffectedcellmigration. Wescreened foreffec-
tive siRNA constructs using the mU6pro vector (Yu et al.,
2002) and transfected NIH3T3 cells with plasmids
expressing red fluorescent protein (RFP), full-length
FLAG-MEKK4, and either mU6pro vector alone or con-
taining siRNA#555, siRNA#555 with four point mutations
(siRNA#5554pt), orsiRNA#555scrambled (siRNA#555SCR)sequences (see Experimental Procedures for sequence
details). Immunostaining for FLAG revealed that
siRNA#555 dramatically reduced FLAG-MEKK4 expres-
sion compared to mU6pro alone (data not shown) or
siRNA#5554pt and siRNA#555SCR (Figure S2A). Western
blot analysis confirmed the knockdown of both FLAG-
MEKK4 (Figure S2B) and endogenous MEKK4 (Fig-
ure S2C). In addition, we found that 48 hr post-in utero
electroporation of E14.5 FB, siRNA#555 dramatically
reduced MEKK4 mRNA compared to the contralateral
hemisphere or siRNA#555SCR (Figure S2D). Thus,
siRNA#555 can be used to knockdown MEKK4 expres-
sion both in vitro and in vivo.
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Progenitors
We hypothesized that knocking down MEKK4 in vivo
might inhibit cell migration in the developing FB. To
test this, we used in utero electroporation to deliver
a 3:1 mixture of MEKK4 siRNA to RFP. Because the
siRNA-containing mU6pro vector does not express a re-
porter gene, we performed control experiments which
showed that coelectroporation of RFP and GFP results
in w90% cotransfection (data not shown) which was
similar to other reports (Bai et al., 2003). We electropo-
rated E14.5 FB with RFP alone (n = 7), siRNA control (siR-
NA#5554pt [n = 2], or siRNA#555SCR [n = 2]) plus RFP, or
siRNA#555 and RFP (n = 7) and analyzed the fates of
RFP+ cells at P0. In controls, we found that the majority
of RFP+ cells were located within the CP (Figure 3A). In
contrast, electroporation of siRNA#555 resulted in
Figure 2. Failure of BrdU-Positive Cells to Leave the Ventricular Sur-
face and PVH in MEKK4-Deficient Forebrain
(A and B) Dams were exposed to BrdU at E14.5 and the forebrain
(FB) was analyzed at E18.5.
(A) Analysis of a PVH from a MEKK42/2 ‘‘big FB’’ phenotype stained
for BrdU (green), TUJ1 (red), and TO-PRO-3 (blue). Compared to
adjacent neocortex (asterisk), heavily labeled BrdU+ cells (arrows
in BrdU) colocalized with TUJ1+ (arrows) in the PVH. (A0) Higher mag-
nification of the boxed region in (A) shows heavily labeled BrdU+/
TUJ1+ cells (arrows) within the heterotopia. Bars = 50 mm.
(B) Example of aMEKK4+/+ andMEKK42/2with a ‘‘small FB’’ pheno-
type (sm FB) where BrdU+ cells (green) failed to leave the VZ surface
compared to +/+. Nuclei were labeled with propidium iodide (red).
Bar = 100 mm.dramatically more RFP+ cells within the corpus callosum
(CC) and PZ and considerably fewer cells within the CP
(Figure 3A). In one E15.5 dam, we electroporated siR-
NA#555SCR plus GFP into the left hemisphere and
siRNA#555 plus RFP into the right hemisphere. Analysis
at P0 revealed that the majority of RFP+ cells failed to
enter the CP compared to GFP+ cells (Figure 3B). Quan-
tification of RFP+ somas throughout the FB showed that
compared to controls, siRNA#555 resulted in w50%
fewer cells reaching the CP and significantly more cells
within the CC (w40% compared to w3% in controls)
and PZ (w3% compared to w0.5% in controls;
Figure 3C). Inhibited migration by siRNA#555 was also
observed after 72 hr (data not shown). In additional
experiments, we exposed electroporated mice to BrdU
24 hr after electroporation (E15.5). We reasoned that at
electroporated sites, since nearly all cells in the VZ would
be RFP+, exposure to BrdU should label a significant
percentage of RFP+ cells. Analysis of BrdU and RFP at
P0, after transfection with MEKK4 siRNA#555, revealed
many RFP+/BrdU+ cells in the CC compared to control
(RFP alone) where most RFP+/BrdU+ cells were located
in the CP (Figure S3). In siRNA#555-transfected brains,
there appeared to be fewer BrdU+ cells in the CP region
located above the heterotopia compared to adjacent
neocortical areas or comparable regions of the opposite
hemisphere (Figure 3D). In separate experiments, we
tested whether some cells arrested at the VZ surface
were neuronal by coelectroporating siRNA#555 with
Ta1 Venus-GFP (a neuronal-specific promoter [Gloster
et al., 1999]). Six days after coelectroporation, many
GFP+ cells were stuck at the VZ surface in siRNA#555-
transfected brains compared to control (Figure 3E).
Although examination of radial glial morphology at a
range of postelectroporation time points (e.g., 24, 72,
and 96 hr) did not show grossly affected morphology
(data not shown), we cannot rule out that siRNA#555
resulted in subtle radial glial defects affecting migration.
In any event, these results suggest that MEKK4 is impor-
tant for neuronal progenitor cells to migrate away from
both the VZ and IZ.
DeletingMEKK4 in mice results in enhanced apoptosis
wE8.5–9.0 and frequent FB degeneration (Chi et al.,
2005). We therefore hypothesized that MEKK4 RNAi
may enhance cell death if MEKK4 additionally plays an
antiapoptotic role. Analysis of the morphology of RFP+
cells at P0 in brains transfected with siRNA#555 revealed
many unhealthy, apoptotic profiles in the CP, CC, and
VZ/SVZ (data not shown). We stained for apoptotic nu-
clei using the TUNEL method and found that compared
to RFP alone (or 555SCR), siRNA#555 resulted in many
TUNEL+/RFP+ cells in the VZ/SVZ, CC, and CP (Fig-
ure S4). Together, the results suggest that in addition
to playing a role in neuronal migration, MEKK4 may
also have an antiapoptotic function that ensures the
survival of proliferating, migrating, and differentiating
neurons.
Compromised Integrity of the VZ Surface May
Predispose MEKK4 Mutants to PVH
Radial glial endfeet form an adhesive lining at both the VZ
and pial surface (Levitt and Rakic, 1980), and defects in
these structures could predispose mice to PVH. Integ-
rins are involved in the assembly of the basal lamina
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793Figure 3. MEKK4 siRNA Impairs Radial Migration of Neocortical Neurons
(A, C, D, and E) In utero electroporation was performed at E14.5 and forebrains were examined at P0.
(A) Transfection with RFP alone (left) resulted in the majority of cells reaching the CP. In contrast, RFP+ cells cotransfected with siRNA#555
(arrows, right) were largely stuck in the CC. Bar = 200 mm.
(B) Example of an E15.5 brain electroporated with siRNA#555SCR and GFP into the left hemisphere and siRNA#555 and RFP into the right hemi-
sphere. At P0, siRNA#555 caused the majority of RFP+ cells to arrest in the CC, whereas most GFP+ cells reached the CP. Bar = 50 mm.
(C) Quantification of the percentage of RFP+ cells in the PZ, CC, or CP from mice electroporated at E14.5 and sacrificed at P0. siRNA#555 (black
bars) causedw50% reduction of cells in the CP and significantly more cells to accumulate in the CC and PZ compared to RFP alone (white bars)
or siRNA#555SCR (gray bars). The data represent the mean 6 SEM. *p < 0.01 (ANOVA).
(D) In utero electroporation of fetuses at E14.5, exposure of dams to BrdU at E15.5, and analysis at P0. Example of a brain electroporated with
siRNA#555 shows a heterotopia (arrows) beneath the CP (ipsilateral) that contained many BrdU+ cells (arrows). In the ipsilateral area of CP
(corresponding to the asterisk in lower panel), reduced BrdU immunostaining is observed over the heterotopia compared to the adjacent CP
or opposite hemisphere (contralateral). Bar = 100 mm.
(E) Electroporation of pTa1 Venus-GFP alone (E0) or with siRNA#555 (E00–E00 00) and immunostaining for GFP. (E0) Electroporation of pTa1 Venus-
GFP alone (2555) resulted in most GFP+ cells reaching the cortical plane (not visible in picture) with their axonal projections (arrow). (E00)
Coelectroporation with siRNA#555 (+555) resulted in many GFP+ cells at the VZ surface. (E00 0 and E00 00) Higher magnifications of the boxed areas
in (E00) revealed cell bodies that remained at the VZ surface (arrowheads).and radial glial endfeet anchoring. Defects in integrin
receptors, integrin-linked kinases, as well as dystrogly-
can complexes have been implicated in the pathogene-
sis of breeches at the outer cortical surface (Moore
et al., 2002; Niewmierzycka et al., 2005; Schmid et al.,
2004). We therefore examined whether there were extra-
cellular matrix abnormalities inMEKK42/2FB by probing
for laminin, a glycoprotein that binds cell membranes via
integrin receptors and the dystroglycan complex (Cam-
pos et al., 2004; Powell and Kleinman, 1997). Consistent
with previous studies, laminin was detected in the pia,
blood vessels, and along the VZ surface of MEKK4+/+
FB (Figure 4A). Coimmunostaining with RC2, a radial glial
marker, revealed laminin and RC2-labeled radial glial
endfeet at the VZ surface (Figure 4A). In contrast, we
found areas of severe discontinuity in laminin staining
at both the VZ and pial surface of MEKK42/2 small (Fig-
ures 4B and 4D) and big FB (Figure 4C) phenotypes.
The morphology and organization of RC2+ fibers was
markedly disrupted at sites where laminin was disrupted
(Figure 4B). Remarkably, RC2+ fibers adjacent to PVH
appeared to navigate around PVH areas to establish
a normal pattern of radial glial scaffolding in the upperregions of the CP even when the underlying areas were
severely disrupted (Figure S5). Additionally, at sites of
ectopias, RC2+ fibers were observed extending beyond
the pia mater (Figure 4D). These observations might
explain how a relatively organized CP forms over PVHs.
Furthermore, staining ofMEKK42/2big FB with the F-ac-
tin binding probe, phalloidin, appeared to show disrup-
tions of the adherens junctions complexes along the VZ
surface (Figure 4E). Notably, these disruptions also
showed invasion of nuclei into the ventricular space
(Figure 4E). Together, these results suggest that the
loss of MEKK4 may lead to defects in the VZ surface
integrity that promote the formation of PVH.
Elevated Fln Expression in MEKK42/2 Mice
Because bilateral PVH are common in patients with loss-
of-function FLN-A mutations (Fox et al., 1998; Sheen
et al., 2001), we used western blot and immunostaining
to analyze Fln levels in MEKK4 +/+, +/2, and 2/2 FB. Sur-
prisingly, western blot analysis at E15.5 (Figures 5A and
5B) or E16.5 (Figure 5C) revealed that MEKK42/2 FB (re-
gardless of small or big phenotype) showed increased
Fln compared to MEKK4+/2 or +/+ FB. Fln-A and Fln-B
Neuron
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brain (Sheen et al., 2002). To determine which isoform
contributed to increased Fln inMEKK42/2FB, we probed
blots with Fln-A- and Fln-B-specific antibodies. We
found that MEKK4-deficient FB showed increased
Fln-A (Figure 5B) and Fln-B (Figure 5A). To determine
where these changes occurred in MEKK42/2 FB, we im-
munostained E17.5 FB with phospho-Fln-A, Fln-A, and
Fln-B antibodies. In controls, all Fln antibodies showed
Figure 4. Defects along the Ventricular and Pial Surface inMEKK42/2
Brain
(A–D) Laminin (green) and RC2 (red) immunostaining and TO-PRO-3-
labeled nuclei (blue) in E17.5–18.5 wild-type (+/+) and MEKK42/2
small (sm) and big FB.
(A) Laminin expression in+/+was observed at the pial surface, blood
vessels (bv), and along the VZ surface. (A0) RC2+ fibers appeared
normal in +/+ connecting the VZ and pial surface. (A00) Higher magni-
fication of the boxed region in (A0) shows RC2+ radial glial endfeet
and laminin coincided along the VZ surface. Bar in (A) (also for A0,
B, B0, and D) = 50 mm, (A00) (also for B00, C, and D0) = 20 mm.
(B) Laminin staining in 2/2 sm FB showed an area of disrupted VZ
labeling (arrows) at the site of a heterotopia. The lack of pial surface
labeling was due to the meninges being separated away from the
section. (B0) RC2+ fibers are disrupted at the heterotopic region
(boxed area). (B00) Higher magnification of the boxed area in (B0)
shows abrupt ending of radial glial endfeet (arrowheads) that also
corresponded to a lack of laminin immunoreactivity.
(C) Discontinuous laminin staining (arrows) along the VZ surface in
2/2 big FB mutants.
(D) An example of an ectopia in2/2 sm FB that was associated with
both a breech in the pial surface and extension of RC2+ fibers into
the ectopia. (D0) Higher magnification of the boxed region in (D)
shows disrupted pia label (large arrowhead) and extension of
RC2+ fibers into the ectopia (small arrowheads).
(E) Phalloidin-labeling of F-actin (green) revealed defects in the con-
tinuity of the adherens junctions complexes (aj) along the VZ surface
in MEKK42/2 big FB (arrows in middle, right panels) compared to
+/+. Nuclei (blue) appeared to be invading the ventricular space at
these disrupted sites (arrows). Bars (mm) representing middle (and
left) panel = 20 and right = 50.comparable immunostaining patterns with the strongest
signal located in the IZ and CP (Figures 5D, 5E, and S6).
Blood vessel staining was also detected with some of
the Fln antibodies (Figures 5E and S6). In contrast to
MEKK4+/+ or +/2 mice, we found that phosphorylated
Fln-A was expressed within PVH of MEKK42/2 FB
(Figure 5D) that were also positive for Fln-A and Fln-B
(Figure S6). In addition, we observed cells along the VZ
surface (particularly at sites where the integrity of the
VZ surface appeared disrupted) and in the IZ (data not
shown) that appeared to express abnormally high levels
of Fln-A and phospho-Fln-A compared to MEKK4+/+
(Figures 5E–5H). Double immunostaining with Tbr1
confirmed that these highly Fln-A-positive cells were
neuronal (Figures 5F–5H).
Overexpression of Fln-A in mouse FB can restrict mi-
grating cell polarity to a more radial orientation as cells
pass through the IZ (Nagano et al., 2004). Similarly, closer
analysis of TUJ1 immunoreactivity in MEKK4-deficient
FB (big or small phenotype) in nonheterotopic regions
showed many radially oriented TUJ1+ processes enter-
ing the IZ compared to control (Figure S7). Together,
these results suggest that MEKK4 deletion may lead to
enhanced or dysregulated Fln expression that subse-
quently impairs the migration and morphology of many
neocortical progenitors.
GST-SEK1 Can Precipitate MEKK4 and Fln-A
MKK4/SEK1 is a MAP2K reported to bind FLN-A in mel-
anoma cells and serves as one substrate for MEKK4
(Gerwins et al., 1997; Marti et al., 1997). Therefore,
MKK4/SEK1 could serve as a mechanism that brings
MEKK4 and Fln-A together during neocortical develop-
ment. To test this, we incubated COS-7 or E17.5 FB cell
lysates with GST-MKK4/SEK1 and probed blots for
endogenous MEKK4 and Fln-A. Compared to glutathi-
one-agarose beads or beads coated with GST, GST-
MKK4/SEK1 precipitated endogenous MEKK4 and
Fln-A (Figure 6A) from the same extracts. These results
suggest that MEKK4 may be part of an intracellular com-
plex with Fln-A via MKK4/SEK1. During development,
this signaling pathway could play a role in coordinating
neuronal migration.
Knockdown of MEKK4 Enhances Fln-A
Phosphorylation on Ser2152 via MKK4/SEK1
FLN-A phosphorylation on Ser2152 has been implicated in
providing resistance to FLN-A cleavage and mediating
actin cytoskeletal assembly (Garcia et al., 2006; Vadla-
mudi et al., 2002; Woo et al., 2004). To test whether
MEKK4 RNAi can affect Fln-A phosphorylation, protein
extracts were collected from NIH3T3 cells that were
either mock or siRNA#555 transfected and cultured for
96 hr. Western blot analysis revealed enhanced phos-
pho-Fln-A relative to total Fln-A signal in siRNA#555-
transfected compared to control cultures (Figures 6B
and 6C). Therefore, MEKK4 suppression by RNAi can
lead to increased Fln-A phosphorylation at Ser2152.
Next, we tested whether the increased Fln-A phos-
phorylation at Ser2152 induced by MEKK4 RNAi could
be blocked by cotransfection with a dominant-negative
form of MKK4/SEK1 (dnSEK1). We found that siRNA#555
increased Fln-A phosphorylation as early as 24 hr
posttransfection; however, when cotransfected with
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MEKK42/2 Forebrain
(A) E15.5 MEKK4+/+, +/2, and 2/2 FB extracts.
Compared to +/+ and +/2, MEKK42/2 with
big or small FB had elevated Fln. For two
of the MEKK42/2 (big and small [Sm] FB),
probing the same blots with a FLN-B-specific
antibody showed that Fln consisted of ele-
vated Fln-B. GAPDH was a loading control.
(B) Western blot of E15.5 FB extract showed
elevated Fln-A in a MEKK42/2 with a small
FB.
(C) Western blot of E16.5 FB showed elevated
total Fln in theMEKK42/2. b-actin was a load-
ing control.
(D) Immunostaining of E17.5 FB for phospho-
Fln-A (pFln-A) using mAb(p2152FLN-A). In
control, p-Fln-A was highly expressed in
the IZ and CP compared to the MEKK42/2
where p-Fln-A persisted to the proliferative
zone (PZ) surface at sites of PVHs (arrows).
Bar = 100 mm.
(E) Immunostaining of Fln-A (mAb(4–4))
showed a similar pattern to pFln-A. Magnified
views of Fln-A expression (red) from left hand
panels are displayed to the right. InMEKK4+/+
(upper panels), Fln-A expression was low in
the PZ and higher in the IZ. Microglia (arrows)
and blood vessels (BV) were also labeled. In
contrast, MEKK42/2 (big FB) ectopically showed areas of PZ that appeared highly positive for Fln-A. Lower panels show Fln-A-positive cells
with radially oriented fibers (arrowheads in magnified view) could be found within the PZ where the surface of the PZ was disrupted. Bar = 20 mm.
(F) Fln-A (green) and Tbr1 (red) immunostaining showed that in MEKK42/2 big FB mutants (right panel), heavily labeled Fln-A cells were both
Tbr1+ (arrows) and Tbr12 (arrowheads). No Tbr1 was observed along the VZ surface in +/+ (left panel).
(G) Example of Fln-A+/Tbr1+ (arrows) cells at the VZ surface in MEKK42/2 small FB.
(H) An adjacent section to that in G showed Tbr1+ cells also stained for pFlnA (arrowheads). Bar = 10 mm.dnMKK4/SEK1, the phosphorylation of Fln-A was de-
creased (Figures 6D and 6E). These results suggest
that in the absence of MEKK4, phosphorylation of Fln-A
at Ser2152 depends on MKK4/SEK1 signaling and that
under normal conditions, MEKK4 could influence Fln-A
phosphorylation.
Overexpression of Wild-Type FLN-A Can Disrupt
Radial Migration
Increased Fln-A can inhibit cell migration in nonneuronal
cells and alter the morphology of migrating neurons
(Cunningham et al., 1992; Nagano et al., 2004). Loss of
MEKK4 resulted in increased Fln-A that was associated
with regions of failed migration initiation. To test whether
increased Fln-A can inhibit neuronal migration, we over-
expressed a full-length human wild-type (WT) FLN-A with
GFP and analyzed GFP+ cell distribution within the CP
and subplate (SP) after 96 hr. We found that WT FLN-A
overexpression resulted in significantly fewer cells in
upper CP and more cells in deeper CP and SP compared
to control (GFP plus empty cDNA3.1 vector; Figures 7A
and 7B). These data suggest that mutations leading to
excessive Fln-A could impair neuronal migration.
Discussion
Malformations of human FB are often attributed to genes
that regulate neuronal migration (Feng and Walsh, 2001;
Rakic, 1988a). Our data suggest a relationship between
MEKK4 and Fln-A that not only influences migration initi-
ation but also the integrity of the neuroependymal lining.
Loss of MEKK4 dramatically disrupts the amount andphosphorylation of Fln-A, possibly contributing to the
pathogenesis of PVH.
MEKK4 Expression in the Mammalian Brain
MEKK4 is highly expressed in the developing murine and
human neural tube and persists throughout peak cortical
neurogenesis into adulthood (Figure S1 and Abell et al.
[2005], Chan-Hui and Weaver [1998], Chi et al. [2005]).
Two splice variants have been detected from mouse
brain cDNA, MEKK4a and MEKK4b (Gerwins et al.,
1997). MEKK4a differs from MEKK4b by an additional
52 amino acid sequence in the noncatalytic domain.
The targeting strategies of both MEKK42/2 mice and
siRNA would predictably result in deletion or reduction
of both isoforms. Whether these two isoforms are differ-
entially regulated in the developing or adult CNS is
unknown. The widespread expression of MEKK4 in the
CNS suggests its function may extend to other neural
cell types and depend on local environmental stimuli.
Neuronal Migration Defects in MEKK42/2
and RNAi-Treated Brains
With the exception of FLN-A and ARFGEF2, little is
known about the molecular regulators of migration initi-
ation in developing FB (Bielas et al., 2004; Marin and
Rubenstein, 2003). Our data suggest that MEKK4 is
involved in this process. About 50% of MEKK42/2 mice
developed bilateral PVHs that largely consisted of differ-
entiated neurons (Figure 1). Exposure ofE14.5MEKK42/2
mice (big or small FB) to BrdU and analysis at E18.5
revealed that cells within PVH failed to leave the VZ sur-
face (Figure 2). SiRNA#555 produced heterotopias more
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of neuronal progenitors remained at the VZ surface (Fig-
ure 3). The full effect of siRNA may be delayed until
endogenous MEKK4 is completely degraded and cells
have exited the VZ/SVZ. Because of these temporal
and spatial differences, if migrating cells use different
mechanisms to exit the VZ than to exit the CC, an
RNAi-mediated strategy may differentially disrupt the
signaling pathways that govern each event. In the
Figure 6. MEKK4 Interaction and Regulation of Fln-A Phosphoryla-
tion via MKK4/SEK1
(A) Ten micrograms of GST-MKK4/SEK1 (GST-SEK1) was incubated
in eitherw500 mg of COS-7 lysate orw1 mg E17.5 mouse FB lysate.
As controls, equivalent amounts of COS-7 or FB lysates were incu-
bated in glutathione-agarose beads (Beads) or beads preincubated
in GST (GST-beads). One percent of lysates (1% input) were run for
COS-7 or FB lysates. The upper blot was probed with anti-MEKK4
(CT) antibody and shows GST-MKK4/SEK1 precipitated endoge-
nous MEKK4 in both COS-7 and FB lysate. Twenty micrograms of
E15.5 MEKK42/2 FB lysate was run as a control. A doublet band is
precipitated in both COS-7 and FB lysate with the upper band corre-
sponding to MEKK4. The lower blot was probed using an anti-Fln-A
antibody and showed that GST-MKK4/SEK1 also precipitated
endogenous Fln-A from COS-7 and FB lysates.
(B) NIH3T3 cells were mock or siRNA#555 transfected and cultured
for 96 hr. Lysates (20 mg/lane) from different mock and siRNA#555
(555)-transfected wells were western blotted and probed for phos-
pho-Fln-A (Ser2152) (upper blot), Fln-A (middle blot), and MEKK4
(lower blot) antibodies. Increased phosphorylation of Fln-A was
observed after transfection with siRNA#555.
(C) The relative phospho-to-total Fln-A band intensities were quan-
tified for five separate transfections/group which showed increased
Fln-A phosphorylation in siRNA#555-transfected cultures. The data
represent the mean 6 SEM.
(D) NIH3T3 cells were either untransfected (Mock) or transfected
with dominant-negative SEK1 (dnSEK1), siRNA#555, or dnSEK1
plus siRNA#555. Lysates were collected at 24 hr, western blotted,
and probed as in (C). The blot shows increased Fln-A phosphoryla-
tion (p-Fln-A) after siRNA#555 that was not observed when cotrans-
fected with dnSEK1.
(E) Quantification (as in [C]) of the results in (D) for at least 5–6 sep-
arate transfections/group. The enhanced Fln-A phosphorylation
after siRNA#555 was blocked by cotransfection of dnSEK1. The
data represent the mean 6 SEM.MEKK42/2 FB, the complete loss of MEKK4 may have
the most severe effect on migrating cells at sites of VZ
surface abnormalities, resulting in VZ surface arrest.
Notably, these were sites associated with enhanced
Fln-A expression (Figure 5). Additionally, the abnormal
orientation of TUJ1+ fibers in the IZ of nonheterotopic
regions of neocortex suggests that many MEKK42/2
cells may be prone to subtle defects in migration
(Figure S7). Since MEKK4-deficient neurons were ar-
rested at both the VZ surface and beneath the CP,
MEKK4 may be essential for both the initial and interme-
diate stages of migration.
JNKs can be activated by MEKK4, and JNK can phos-
phorylate DCX (Gdalyahu et al., 2004; Gerwins et al.,
1997). However, JNK activity was not altered in
MEKK42/2 or MEKK4K1361R CNS (Abell et al., 2005; Chi
et al., 2005), and we did not observe altered total or phos-
pho-DCX by western blot (data not shown). Conceivably,
insufficient MEKK4 signaling could transiently disrupt
JNK signaling, in turn affecting DCX activity arresting
cells beneath the CP. This would be consistent with the
effects of DCX siRNA (Bai et al., 2003; Ramos et al.,
2006). Because MEKK42/2 mice display both affected
migration and enhanced apoptosis (Figures 2 and 3 and
Chi et al. [2005]), we propose that the MEKK4 siRNA-
treated brains reflect phenomena observed in mutants
with both big and small FB phenotypes. Though en-
hanced apoptosis may be a due to an accumulated effect
of RNAi, the data further support a prosurvival role for
MEKK4 during development. Whether arrested cell mi-
gration leads to the onset of apoptosis in siRNA-trans-
fected cells or vice versa is not clear. Although the degree
to which the mechanisms underlying knockout and RNAi
phenotypes are shared is unclear, taken together our
data support a critical role for MEKK4 in cortical neuronal
migration.
Abnormalities in the Neuroependymal Lining
after MEKK4 Deficiency
The putative cause of most PVH is a loss of function of
FLN-A resulting in arrested neurons at the VZ surface
(Feng and Walsh, 2004). Alternatively, PVH may arise
from defects in cell adhesion or the extracellular matrix
(ECM) lining the ventricular surface (Lu et al., 2006; Sheen
et al., 2005). MAPK signaling is activated by b-integrins
and FLN-A (Campos et al., 2004; Scott et al., 2006), sug-
gesting that dysfunctional MAPK signaling could alter
critical signaling cascades that maintain the strength of
the VZ surface. Notably, a recent study suggests that
FLN-A may span the plasma membrane and interact
with integrins within the ECM (Bachmann et al., 2006).
Therefore, mutations that alter FLN-A expression or
function could impact both migrating cells and the
ECM lining the lateral ventricles. Consequently, it is not
clear whether PVH arise from autonomous cell migration
defects, nonautonomous effects on the neuroependy-
mal lining, or both.
Here, we provide evidence in MEKK4-deficient mice
for a breakdown of the VZ (and pial) surface revealed
by disrupted laminin staining (which binds integrins)
that was associated with disorganized radial glial end-
feet (Figure 4). Although not frequently observed, some
siRNA#555-transfected brains at P0 did show pro-
nounced disruption of the VZ surface at electroporated
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797Figure 7. FLN-A Overexpression Inhibits
Neuronal Migration
(A) E14.5 cortex was electroporated with GFP
and pcDNA3.1 vector (GFP + cDNA3.1) or
GFP and pcDNA3.1 expressing full-length
wild-type FLN-A (WT-FLN-A). After 96 hr,
more GFP+ cells were observed in deeper
CP of WT-FLN-A (right) compared to control
(left). Nuclei (blue) were stained with DAPI.
(B) Quantification of GFP+ cell distribution at
96 hr was determined by placing a grid
(divided into six bins) spanning the upper
and deeper CP and SP over the electroporated region. Significantly more GFP+ cells were located in the deeper CP and SP at 96 hr after
WT-FLN-A (n = 16 sections from four embryos) overexpression (solid) compared to GFP control (dashed) (n = 12 sections from three embryos).
The data represent the mean 6 SEM. Repeated measures ANOVA (p < 0.01).sites (Figure S4C). Irrespective of VZ integrity, neuronal
precursors were clearly stuck at the VZ surface of
RNAi-exposed mice (Figure 3E), suggesting a possible
intercellular signaling defect between radial glia and
affected neuronal precursors. The complete deletion of
MEKK4 may cause more severe, but incompletely pene-
trant, effects on radial glial scaffolding at the VZ surface
due to compensatory factors (Figure 4).
Because enhanced apoptosis was observed in both
MEKK4 knockout and siRNA, death of radial glia may
also compromise the integrity of the VZ surface and af-
fect adjacent radial glial morphology and migrating cells.
MEKK4 has been shown to mediate the Wnt signaling
pathway (Luo et al., 2003), which when disrupted causes
radial glial scaffolding defects (Zhou et al., 2004). We
found that radial glial abnormalities and Fln-A upregula-
tion typically colocalized inMEKK42/2 FB. Although Fln-
A overexpression (Figure 7) did not reveal gross defects
in radial glia morphology or VZ surface integrity (data not
shown), we cannot rule out subtle defects in these struc-
tures that impaired the migration process. Alternatively
wild-type FLN-A overexpression may preferentially dis-
rupt migrating neurons. In any event, proper MEKK4 sig-
naling may be required at both the inner and outer corti-
cal limits to maintain the integrity of the neuroependymal
lining which when compromised allows cells to enter the
ventricular space (or breach the pial lining) contributing
to PVH pathogenesis. How these defects lead to im-
paired migration is unclear but is likely attributable to
changes in molecules that normally regulate migration
initiation.
Loss of MEKK4 Enhances Fln-A Expression
and Phosphorylation
Fln-A is expressed in developing FB and regulates actin
dynamics essential to cell motility (Lu et al., 2006;
Nagano et al., 2002; Sheen et al., 2002; Stossel et al.,
2001). Consistent with other reports, we showed that
Fln expression (including phosphorylated, A, and B iso-
forms) was low within wild-type VZ (with the exception
of blood vessel and microglia staining consistent with
a proposed role for FLN-A in blood vessel development
[Kakita et al., 2002]) and high in the IZ and CP (Figures
5 and S6). In contrast, we observed elevated Fln-A, phos-
pho-Fln-A, and Fln-B within MEKK42/2 FB. PVHs ex-
pressed high levels of Fln isoforms compared to control
VZ, and ectopic sites (especially where the VZ surface
was disrupted) displayed Tbr1+ neurons with excessive
Fln-A (Figure 5). These results suggest that MEKK4 dele-tion causes ectopic increases in Fln-A and subsequent
inhibition of neuronal migration. Whether or not in-
creased Fln-A is also directly responsible for defects in
the neuroependymal lining remains unclear.
Can MEKK4 influence Fln-A function? MAPK signaling
complexes are connected by protein scaffolds within the
cytoplasm which include Fln-A (Feng and Walsh, 2004;
Morrison and Davis, 2003). We show that MKK4/SEK1
may serve to bridge MEKK4 and Fln-A as both molecules
precipitated from FB (Figure 6). Further, MEKK4 siRNA
enhanced Fln-A phosphorylation that was blocked by
dnMKK4/SEK1. MKK4/SEK1 binds but does not appear
to phosphorylate Fln-A in vitro (Marti et al., 1997), al-
though whether MKK4/SEK1 directly phosphorylates
Fln-A at Ser2152 in the brain is unknown. Thus under nor-
mal conditions, MEKK4-MKK4/SEK1 signaling may act
to inhibit Fln-A phosphorylation via downstream targets.
In the absence of MEKK4, these targets may overphos-
phorylate Fln-A at Ser2152. These data suggest that
MEKK4 signaling could influence Fln-A phosphorylation
and, as discussed below, alter its expression.
Consequence of Increased Fln-A on Neuronal
Migration
Loss-of-function FLN-A is clearly associated with defec-
tive neuronal migration, but our findings are consistent
with multiple lines of evidence that suggest excess
Fln-A also affects migration. Nonneuronal studies have
shown that migration depends on the intracellular con-
centration of FLN-A and that too little or too high FLN-A
can impede cell migration (Cunningham et al., 1992).
Similarly, increased FLN-A binding to b-integrin can in-
hibit migrating cells (Calderwood et al., 2001), and since
both molecules are present along the VZ surface
(Campos et al., 2004; Lu et al., 2006), abnormally high
Fln-A could increase Fln-A-b-integrin binding impairing
migration away from the VZ surface.
Fln-A expression is controlled both genetically and
molecularly. At the genetic level, mechanical force in-
duction of b1-integrin receptors can selectively activate
the p38 pathway and induce FLN-A transcription (D’Ad-
dario et al., 2002). Notably, we also observed increased
p38 phosphorylation after MEKK4 RNAi (Figure S8).
Why in vitro studies did not show increased total Fln-A
like our mutants was puzzling and may reflect intrinsic
differences between neurons and fibroblasts or require
more time for significant Fln-A accumulation to occur.
Molecular studies have shown that Fln-A phosphory-
lation on Ser2152 confers resistance to calpain cleavage
Neuron
798and is required for p21-activated kinase-1-mediated
actin cytoskeletal assembly (Garcia et al., 2006; Vadla-
mudi et al., 2002). Enhanced Fln-A phosphorylation at
Ser2152 was observed in MEKK42/2 brains and after
siRNA (Figures 5 and 6). Therefore, enhanced Ser2152
phosphorylation may prevent Fln-A cleavage or de-
gradation and result in Fln-A accumulation that sub-
sequently affects actin dynamics during neuronal
migration. Alternatively, FILIP (Fln-A-interacting protein)
is a potent degrader of Fln-A and is expressed in devel-
oping FB. FILIP is thought to maintain a gradient of
Fln-A such that expression is low in the VZ and higher
toward the IZ and CP (Nagano et al., 2002; Sato and
Nagano, 2005). FILIP siRNA (which increases Fln-A)
significantly altered the morphology of migrating neu-
rons. Thus, future studies should examine whether FILIP
activity is altered in MEKK42/2 mice or whether FILIP
is itself regulated by MEKK4 (or other MAP3K pathways).
In any event, mechanisms are in place in the cortical PZ
to maintain low Fln-A (Sato and Nagano, 2005). Over-
expression of wild-type Fln-A was reported to affect
the morphology of migrating neurons (Nagano et al.,
2004). Here, we add to that finding and show that wild-
type FLN-A overexpression can delay migration into
the CP (Figure 7). Our findings suggest that MEKK4
deficiency results in an overall increase in Fln-A. Cells
with excessively high Fln-A may have impaired migration
initiation, while those with moderately increased Fln-A
may have milder defects, including arrested migration
in the IZ and disrupted morphology. Therefore, muta-
tions resulting in increased Fln-A may impair neuronal
migration.
MEKK4 as a Candidate PVH Gene
MEKK4-deficient and MEKK4K1361R mice display a range
of malformations including neural tube closure defects,
skeletal anomalies, and body wall closure defects (om-
phalocoele; Abell et al. 2005; Chi et al., 2005). Interest-
ingly, similar abnormalities have been observed in hu-
mans with mutations in the FLN-A gene leading to FLN-A
gain of function (Robertson et al., 2003; Zenker et al.,
2004). While the majority of PVH phenotypes are caused
by X-linked loss-of-function FLN-A mutations (Fox et al.,
1998; Sheen et al., 2001), there are many cases of PVH
that are not due to FLN-A (Sheen et al., 2003a; Sheen
et al., 2003b; Sheen et al., 2004). Surprisingly, a recent re-
port showed that mice lacking Fln-A do not develop PVH
(Hart et al., 2006). It has been hypothesized that in the
absence of FLN-A, FLN-B can compensate, but this
mechanism has not been well studied. Our data suggests
that genetic mutations resulting in the overexpression or
enhanced phosphorylation of FLN-A may also lead to
PVH. Until recently, Fln-A was thought to localize intra-
cellularly; however, it may have an unappreciated role
on the outer cell surface and interact with ECM proteins
(Bachmann et al., 2006). Thus, the impact of MEKK4 de-
ficiency on Fln-A could affect both neuronal migration
and the ECM that stabilizes the neuroependymal lining.
MEKK4 may therefore be considered a candidate auto-
somal gene underlying human PVH or contribute to the
pathogenesis of PVH in the presence of FLN-A muta-
tions. Exactly how MEKK4 and Fln-A maintain VZ surface
integrity and regulate migration is the focus of future
studies.Experimental Procedures
Mice
The generation of MEKK4-deficient mice on a C57BL/6 background
was described previously (Chi et al., 2005), while timed-pregnant
C57BL/6 mice for in utero electroporation were purchased from
Charles River Laboratories. Fetal stage was calculated from the
day when a vaginal plug was observed (considered as E0.5), and
confirmed by comparing the brain morphology to characterized
embryonic structures (Kaufman, 1995). All animal protocols were in
accordance with Yale University IACUC guidelines.
Histology and Immunocytochemistry
Embryos and postnatal mice were fixed or perfused using Boiun’s
solution or 4% PFA. Brains were either cryoprotected, frozen over
liquid N2 and sectioned on a cryostat, or embedded in wax and sec-
tioned on a microtome. Sections were stained with 0.1% thionin-
Nissl solution or processed for immunostaining using standard pro-
cedures. Tissue for BrdU immunohistochemistry was pretreated for
15 min in 2 N HCl at 40C and rinsed in 0.1 M sodium borate (pH 8.5).
Primary antibodies included rat anti-BrdU (1:100; Accurate), mouse
anti-TUJ1 (1:1000; Sigma), rabbit anti-Fln-A and mouse anti-Fln-A
(mAb(4-4)) (1:200; this antibody was generated as previously de-
scribed [Nakamura et al., 2005] and detects both Fln-A and Fln-C
(data not shown); however, FLN-C is not expressed in brain [Goetsch
et al., 2005]), and mouse anti-phospho-Fln-A(mAb(p2152Fln-A))
(1:200; see below for synthesis detail), rabbit anti-Fln-B (1:500; gift
from S. Shapiro), rabbit anti-Laminin (1:50; Sigma), mouse anti-RC2
(1:2; Developmental Studies Hybridoma Bank), rabbit anti-Tbr1
(1:1000; Chemicon), rabbit anti-GFP (1:1000; Invitrogen), and guinea
pig anti-GLAST (1:8000; Chemicon). Primary antibodies were labeled
with appropriate fluorophore-conjugated secondary antibodies
(Invitrogen). F-actin was labeled with Alexa Fluor 488 phalloidin
(1:40; Invitrogen). Nuclei were stained with propidium iodide (1:2000;
Sigma), TO-PRO-3 iodide (1:1000; Invitrogen), or 406-diamidino-2-
phenylindole dihydrochloride (DAPI) (1:5,000; Sigma). All images
were captured using a confocal LSM 510 NLO system or an Axioplan
2 microscope equipped with epifluorescence and an ApoTome
module (Zeiss).
Production of Monoclonal Antibodies Specific
for Phospho-2152Ser-FLN-A
The serine phosphorylated peptide CRAPp2152SVAN (Cys-
2150Arg-Ala-Pro-phosphoSer-Val-Ala-2155Asn) and the nonphos-
phorylated peptide CRAPSVAN were chemically synthesized by
AnaSpec Inc. Each peptide was coupled to keyhole limpet hemocy-
anin (KLH) through the amino-terminal cysteine of the peptide, with
m-maleimidobenzoyl-N-hydroxysuccinmide ester using a kit. Ap-
proximately 10 mg of peptides conjugated to KLH were immunized
to BALB/c mice, and the hybridoma clones were produced as previ-
ously described (Nakamura et al., 2005). To screen antibodies spe-
cific for phospho-FLN-A by ELISA, recombinant hsFLN-A protein
was used because about 60% of the purified FLN-A from insect cells
was found to be phosphorylated (F.N. and T. Stossel, unpublished
data). The purified FLN-A was treated with alkaline phosphatase
(P-6774, Sigma) to dephosphorylate FLN-A and used as a nega-
tive-control antigen for ELISA. Hybridomas were cloned and adapted
to serum-free media, and monoclonal antibodies were purified as
previously described (Nakamura et al., 2005).
Construction of the FLAG-Tagged MEKK4 Expression Vector
A cDNA clone containing the full-length MEKK4 reading frame
(IMAGE, 5705378) was ordered from ATCC. A FLAG tag (DYKDDDDK)
was inserted into the 50 end of the cDNA by PCR, and the entire
construct was subcloned into the pcDNA3.1/MycHis(2) vector
(Invitrogen). The DNA sequence was confirmed by automatic
sequencing.
siRNA Design, Testing, and In Utero Electroporation
We used the Ambion website (www.ambion.com) to screen siRNA
sequences against the mouse MEKK4 gene (accession #:
NM_011948). BLAST searches of selected sequences revealed no
significant homology to other mammalian genes. Three different
constructs were designed for insertion into the mU6pro vector (Yu
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region of MEKK4 (designated siRNA#555 since the sequence initi-
ated at nucleotide 555 (forward, 50-TTTGAACGGAGCGAGACCATA
AGTTCAAGAGACTTATGGTCTCGCTCCGTTTTTTT-30; reverse, 50-
CTAGAAAAAAACGGAGCGAGACCATAAGTCTCTTGAACTTATGGT
CTCGCTCCGTT-30), Second, construct #555 containing four point
mutations (siRNA#5554pt) (forward, 50-TTTGATCTGAGCGAGACCC
TACGTTCAAGAGACGTAGGGTCTCGCTCAGATTTTTT-30; reverse,
50-CTAGAAAAAATCTGAGCGAGACCCTACGTCTCTTGAACGTAGG
GTCTCGCTCAGAT-30) and third, a scrambled sequence of #555
(siRNA#555SCR) (forward, 50-TTTGAAGTCCACAGAAGCGAGAGTTC
AAGAGACTCTCGCTTCTGTGGACTTTTTTT-30; reverse, 50-CTAGAA
AAAAAGTCCACAGAAGCGAGAGTCTCTTGAACTCTCGCTTCTGTG
GACTT-30). Forward and reverse oligos were ordered from Yale
University DNA Synthesis Laboratory, annealed, phosphorylated,
and ligated into the mU6pro vector as described (Yu et al., 2002).
To screen siRNA efficacy in vitro, NIH 3T3 cells (ATCC) were grown
on poly-L-ornithine and laminin-coated glass coverslips and trans-
fected using Lipofectamine 2000 (Invitrogen) with the following
constructs: pCAGGSmRFP (gift from J. LoTurco), FLAG-MEKK4
(described above), and pmU6pro containing either siRNA#555,
siRNA#5554pt, or siRNA#555SCR constructs. Cells were fixed with
4% PFA 72 hr posttransfection, washed, immunostained with an
anti-FLAG (BioM2) antibody (1:4000; Sigma). To analyze MEKK4
siRNA in vivo, we used in utero electroporation. Briefly, C57BL/6
mice, 14.5 or 15.5 days into gestation, were anesthesized by injection
of ketamine (37 mg/kg)/xylazine (1.9 mg/kg). The uterine horns were
exposed, and 1–3 ml constructs (3:1 ratio of mU6pro:RFP)/0.025%
Fast-Green was microinjected through the uterus into the lateral
ventricles of the cerebral cortex by pulled glass capillaries. Electro-
poration was achieved by discharging 40V across the cortex in
five-pulse series spaced 50 ms apart using a BTX ECM 830 Square
Wave Electroporator. Dams were sutured and placed on heating
pads until they awoke. Some dams received BrdU (50mg/kg i.p.)
24 hr postelectroporation. Electroporated pups were transcardially
perfused at P0 with 4%PFA. Brains were removed, fixed overnight
in 4%PFA, cryoprotected, and frozen over liquid N2.
Quantification of Electroporated Cells
The distribution of RFP+ cells in electroporated brains was examined
on a Zeiss Axioskop 40 epifluorescent microscope and analyzed us-
ing Neurolucida (MicroBrightField Inc.). Brains were cryosectioned
(20 mm) and stained with 40-6-diamidino-2-phenylindole (DAPI;
Sigma) to trace contours of the PZ, CC, and CP on each section
(w6 sections/brain). The soma locations of all RFP+ cells/section
were marked and the data was expressed as the percentage of the
total number of RFP+ cells per contour/total number of RFP+ cells
per section. Statistical analysis was performed using ANOVA with
p < 0.05 considered significant. Error bars are the standard error of
the mean.
Western Blot and GST-SEK1 Pulldown Assay
Protein extracts prepared from mouse and human fetal FB, NIH3T3,
or COS-7 cell lysates were solubilized in ice-cold 13 lysis buffer (Cell
Signaling) supplemented with a protease inhibitor cocktail (1:100;
Sigma) and phosphatase inhibitor cocktail-1 (1:100; Sigma) and 1
mM PMSF. K562 cell lysate was purchased from Upstate Biotechnol-
ogy. Lysates were run at 30 mA on Tris-HCl gels (Bio-Rad) and trans-
ferred onto PVDF (Bio-Rad) at 300 mA for 2 hr. For GST-pulldown as-
says, GST-SEK1 (K129R) (agarose-conjugated; Calbiochem),
glutathione-agarose beads (Sigma), or glutathione-agarose beads
preincubated for 1 hr with 100 mg/ml GST (Sigma) were added to
w500 mg COS-7 or 1 mg E17.5 FB lysate overnight at 4C, washed
four to five times in lysis buffer, eluted, and separated by SDS-
PAGE. For the NIH3T3 experiment involving dnMKK4/SEK1, cells
were transfected with pAd.RSV-MKK4(DN) (Cell Biolabs, Inc.). Im-
munoblot analyses were performed using rabbit anti-MEKK4 (C ter-
minus antibody; 1:5000) (gift from R. Vaillancourt), anti-Fln-A* (Cell
Signaling; *in this study considered a total Fln antibody since it
may crossreact with FLN-B and -C), anti-FLN-A (1:2000), anti-phos-
pho-Fln-A (Ser2152) (1:1000; Cell Signaling), anti-Fln-B (1:500; gift
from S. Shapiro), anti-p38 (1:1000; Cell Signaling), anti-phospho-
p38 (1:2000; Chemicon), and mouse anti-GFP (1:5000; BD Biosci-
ences), anti-b-actin (1:10,000; Sigma), anti-GAPDH (1:10,000;Abcam), and anti-FLAG M2 (1:5000; Sigma) antibodies. Appropriate
HRP-conjugated secondary antibodies (1:10,000; Bio-Rad) were
detected by chemiluminescence (Amersham Biosciences). To deter-
mine band intensity, blots were scanned at 1200 ppi, imported, and
analyzed in Adobe Photoshop 7.0.
Overexpression of FLN-A In Vivo
Plasmids expressing WT-FLN-A (pcDNA3.1-myc-FLN-a) and GFP or
GFP and pcDNA3.1 (empty vector) were electroporated at E14.5 and
mice sacrificed at E18.5. Tbr1 immunostaining and DAPI-labeled
sections (25 mm) were used to draw contours in Neurolucida of CP
including subplate. A blinded observer quantified GFP+ cells by
placing and scaling a grid evenly divided into six bins over the elec-
troporated region that spanned the layer 1/2 boundary (upper) and
subplate (deeper). Distributions of cells were compared using
ANOVA (Repeated Measures).
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/52/5/789/DC1/.
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